Ji-Won Kim

731 total citations
34 papers, 612 citations indexed

About

Ji-Won Kim is a scholar working on Surgery, Genetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ji-Won Kim has authored 34 papers receiving a total of 612 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Surgery, 18 papers in Genetics and 14 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ji-Won Kim's work include Pancreatic function and diabetes (30 papers), Diabetes and associated disorders (15 papers) and Diabetes Management and Research (11 papers). Ji-Won Kim is often cited by papers focused on Pancreatic function and diabetes (30 papers), Diabetes and associated disorders (15 papers) and Diabetes Management and Research (11 papers). Ji-Won Kim collaborates with scholars based in South Korea, United States and Puerto Rico. Ji-Won Kim's co-authors include Kun‐Ho Yoon, Dong‐Sik Ham, Jae‐Hyoung Cho, Seung‐Hyun Ko, Seung‐Hwan Lee, Hae Kyung Yang, Ki‐Ho Song, Marie Rhee, Yu‐Bae Ahn and Min Jung Kim and has published in prestigious journals such as Nature Communications, PLoS ONE and Diabetes.

In The Last Decade

Ji-Won Kim

33 papers receiving 608 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ji-Won Kim South Korea 15 362 208 197 134 104 34 612
Liora S. Katz United States 17 345 1.0× 171 0.8× 331 1.7× 175 1.3× 153 1.5× 28 737
Ruochuan Cheng China 11 181 0.5× 260 1.3× 158 0.8× 61 0.5× 62 0.6× 44 600
Sandra Slusher United States 7 177 0.5× 138 0.7× 359 1.8× 48 0.4× 133 1.3× 8 653
Hwanju Cheon South Korea 9 193 0.5× 94 0.5× 248 1.3× 61 0.5× 87 0.8× 9 567
Nadia Cobo‐Vuilleumier Spain 17 316 0.9× 253 1.2× 285 1.4× 198 1.5× 61 0.6× 30 721
Hyunhee Oh South Korea 10 138 0.4× 91 0.4× 244 1.2× 39 0.3× 75 0.7× 18 501
Byung‐Hyun Park South Korea 14 114 0.3× 70 0.3× 206 1.0× 44 0.3× 99 1.0× 15 531
Markus Jähnert Germany 15 154 0.4× 125 0.6× 322 1.6× 110 0.8× 226 2.2× 40 660
Thor Tejada United States 10 219 0.6× 100 0.5× 366 1.9× 64 0.5× 58 0.6× 14 725
Hongying An United States 8 150 0.4× 127 0.6× 499 2.5× 26 0.2× 170 1.6× 9 723

Countries citing papers authored by Ji-Won Kim

Since Specialization
Citations

This map shows the geographic impact of Ji-Won Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ji-Won Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ji-Won Kim more than expected).

Fields of papers citing papers by Ji-Won Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ji-Won Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ji-Won Kim. The network helps show where Ji-Won Kim may publish in the future.

Co-authorship network of co-authors of Ji-Won Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Ji-Won Kim. A scholar is included among the top collaborators of Ji-Won Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ji-Won Kim. Ji-Won Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Ji-Won, Joonyub Lee, Cheongeun Oh, et al.. (2025). Targeting PGC-1α by miRNA-374 Simultaneously Improve β-Cell Dysfunction and Suppress Hepatic Glucose Overproduction. Diabetes & Metabolism Journal.
2.
Kim, Jinyoung, Kihyoun Park, Min Jung Kim, et al.. (2021). An autophagy enhancer ameliorates diabetes of human IAPP-transgenic mice through clearance of amyloidogenic oligomer. Nature Communications. 12(1). 183–183. 43 indexed citations
3.
Ahn, Yu‐Bae, et al.. (2020). Role of sirtuin-1 (SIRT1) in hypoxic injury in pancreatic β-cells. Journal of drug targeting. 29(1). 88–98. 6 indexed citations
4.
Kim, Min Jung, et al.. (2020). Generation of iPSC-derived insulin-producing cells from patients with type 1 and type 2 diabetes compared with healthy control. Stem Cell Research. 48. 101958–101958. 25 indexed citations
5.
Rhee, Marie, Seung‐Hwan Lee, Ji-Won Kim, et al.. (2016). Preadipocyte factor 1 induces pancreatic ductal cell differentiation into insulin-producing cells. Scientific Reports. 6(1). 23960–23960. 27 indexed citations
6.
Kim, Ji-Won, Shin‐Young Park, Dong‐Sik Ham, et al.. (2016). Suppression of ROS Production by Exendin-4 in PSC Attenuates the High Glucose-Induced Islet Fibrosis. PLoS ONE. 11(12). e0163187–e0163187. 27 indexed citations
7.
Yang, Hae Kyung, Dong‐Sik Ham, Marie Rhee, et al.. (2015). Reversal of Hypoglycemia Unawareness with a Single-donor, Marginal Dose Allogeneic Islet Transplantation in Korea: A Case Report. Journal of Korean Medical Science. 30(7). 991–991. 3 indexed citations
8.
Yang, Hae Kyung, Dong‐Sik Ham, Marie Rhee, et al.. (2015). Long-term Efficacy and Biocompatibility of Encapsulated Islet Transplantation With Chitosan-Coated Alginate Capsules in Mice and Canine Models of Diabetes. Transplantation. 100(2). 334–343. 45 indexed citations
9.
Choi, You‐Jin, Kye Jung Shin, Dae Won Jun, et al.. (2015). Cinnamamides, Novel Liver X Receptor Antagonists that Inhibit Ligand-Induced Lipogenesis and Fatty Liver. Journal of Pharmacology and Experimental Therapeutics. 355(3). 362–369. 16 indexed citations
10.
Kim, Ji-Won, Marie Rhee, Jae‐Hyung Park, et al.. (2014). Chronic effects of neuroendocrine regulatory peptide (NERP-1 and -2) on insulin secretion and gene expression in pancreatic β-cells. Biochemical and Biophysical Research Communications. 457(2). 148–153. 6 indexed citations
11.
Kim, Ji-Won, Shin‐Young Park, Dong‐Sik Ham, et al.. (2014). Targeting PGC-1α to Overcome the Harmful Effects of Glucocorticoids in Porcine Neonatal Pancreas Cell Clusters. Transplantation. 97(3). 273–279. 10 indexed citations
12.
Ham, Dong‐Sik, et al.. (2013). Generation of Functional Insulin-Producing Cells from Neonatal Porcine Liver-Derived Cells by PDX1/VP16, BETA2/NeuroD and MafA. PLoS ONE. 8(11). e79076–e79076. 25 indexed citations
13.
Jung, Mi-Young, Ki‐Sun Kwon, Eunpyo Moon, et al.. (2012). Deregulation of CREB Signaling Pathway Induced by Chronic Hyperglycemia Downregulates NeuroD Transcription. PLoS ONE. 7(4). e34860–e34860. 18 indexed citations
14.
Lee, Young Eun, Ji-Won Kim, Eun‐Mi Lee, et al.. (2012). Chronic Resveratrol Treatment Protects Pancreatic Islets against Oxidative Stress in db/db Mice. PLoS ONE. 7(11). e50412–e50412. 69 indexed citations
16.
Sun, Chenglin, Dong‐Sik Ham, Ji-Won Kim, et al.. (2010). Rapamycin Suppresses the Expansion and Differentiation of Porcine Neonatal Pancreas Cell Clusters. Transplantation. 90(7). 717–724. 8 indexed citations
17.
Kim, Ji-Won, Ji Yang, Chenglin Sun, et al.. (2009). Rosiglitazone protects the pancreatic β-cell death induced by cyclosporine A. Biochemical and Biophysical Research Communications. 390(3). 763–768. 11 indexed citations
18.
Kim, Ji-Won. (2008). Loss of beta-cells with fibrotic islet destruction in type 2 diabetes mellitus. Frontiers in bioscience. Volume(13). 6022–6022. 53 indexed citations
19.
Kim, Ji-Won, Jae‐Hyoung Cho, Seung‐Hyun Ko, et al.. (2007). Transcriptional mechanism of suppression of insulin gene expression by AMP-activated protein kinase activator 5-amino-4-imidazolecarboxamide riboside (AICAR) in β-cells. Biochemical and Biophysical Research Communications. 365(4). 614–620. 6 indexed citations
20.
Rhee, Marie, Ji-Won Kim, Oak‐Kee Hong, et al.. (2005). Characterization of Preadipocyte factor-1 (Pref-1) Expressing Pancreatic Cells. Diabetes & Metabolism Journal. 29(6). 507–516. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026